- Home
- ORC vs GHRS Comparison
ORC vs GHRS Comparison
Compare ORC & GHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORC
- GHRS
- Stock Information
- Founded
- ORC 2010
- GHRS 2018
- Country
- ORC United States
- GHRS Ireland
- Employees
- ORC N/A
- GHRS N/A
- Industry
- ORC Real Estate Investment Trusts
- GHRS Biotechnology: Pharmaceutical Preparations
- Sector
- ORC Real Estate
- GHRS Health Care
- Exchange
- ORC Nasdaq
- GHRS Nasdaq
- Market Cap
- ORC 660.1M
- GHRS 753.0M
- IPO Year
- ORC 2013
- GHRS 2021
- Fundamental
- Price
- ORC $7.11
- GHRS $13.18
- Analyst Decision
- ORC Hold
- GHRS Strong Buy
- Analyst Count
- ORC 3
- GHRS 8
- Target Price
- ORC N/A
- GHRS $30.63
- AVG Volume (30 Days)
- ORC 4.0M
- GHRS 255.8K
- Earning Date
- ORC 10-23-2025
- GHRS 08-07-2025
- Dividend Yield
- ORC 20.28%
- GHRS N/A
- EPS Growth
- ORC N/A
- GHRS N/A
- EPS
- ORC 0.07
- GHRS N/A
- Revenue
- ORC $24,257,000.00
- GHRS N/A
- Revenue This Year
- ORC $68.67
- GHRS N/A
- Revenue Next Year
- ORC $51.70
- GHRS N/A
- P/E Ratio
- ORC $100.17
- GHRS N/A
- Revenue Growth
- ORC N/A
- GHRS N/A
- 52 Week Low
- ORC $5.69
- GHRS $6.00
- 52 Week High
- ORC $9.01
- GHRS $20.50
- Technical
- Relative Strength Index (RSI)
- ORC 49.51
- GHRS 48.52
- Support Level
- ORC $7.03
- GHRS $11.32
- Resistance Level
- ORC $7.20
- GHRS $13.15
- Average True Range (ATR)
- ORC 0.09
- GHRS 0.75
- MACD
- ORC -0.00
- GHRS 0.08
- Stochastic Oscillator
- ORC 60.42
- GHRS 75.61
About ORC Orchid Island Capital Inc.
Orchid Island Capital Inc is a specialty finance company that invests in residential mortgage-backed securities. The principal and interest payments of its RMBS are guaranteed by the Federal National Mortgage Association, the Federal Home Loan Mortgage Corporation, or the Government National Mortgage Association, and are backed by single-family residential mortgage loans. The company's investment portfolio is divided into two categories namely traditional pass-through Agency RMBS; and structured Agency RMBS, such as collateralized mortgage obligations, interest-only securities, inverse interest-only securities, and principal-only securities, among other types of structured Agency RMBS.
About GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.